Sipuleucel-T immunotherapy for castration-resistant prostate cancer.

Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF, IMPACT Study Investigators
N Engl J Med. 2010 363 (5): 411-22

PMID: 20818862 · DOI:10.1056/NEJMoa1001294

MeSH Terms (20)

Aged Aged, 80 and over Androgen Antagonists Antigen-Presenting Cells Antineoplastic Agents Cancer Vaccines Cell Culture Techniques Combined Modality Therapy Disease Progression Double-Blind Method Humans Immunotherapy Infusions, Intravenous Intercellular Adhesion Molecule-1 Kaplan-Meier Estimate Male Middle Aged Proportional Hazards Models Prostatic Neoplasms Tissue Extracts

Connections (1)

This publication is referenced by other Labnodes entities:

Links